Home›Clinical trials›Nebraska

GLP-1 clinical trials in Nebraska: 7 recruiting now

8 sites in one Nebraska city. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (3)

Weight-loss study of tirzepatide

Where: Omaha

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.

Free to join

Who can join: Children and teens 6 to 11 with obesity.

Study record on ClinicalTrials.gov

Children's Hospital & Medical Center, Omaha

Weight-loss study of olatorepatide

Where: Omaha

What: Tests whether a GLP-1 and GIP medicine from Regeneron Pharmaceuticals, olatorepatide, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity or overweight, BMI 27+.

Study record on ClinicalTrials.gov

Velocity Clinical Research - Omaha, Omaha

Type 2 diabetes studies (1)

Type 2 diabetes study of semaglutide

Where: Omaha

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Omaha

Other GLP-1 studies in Nebraska (3)

Fatty liver disease with liver scarring study of survodutide

Where: Omaha

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

University of Nebraska Medical Center, Omaha. 833-602-2368

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Omaha

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

University of Nebraska Medical Center, Omaha. 833-602-2368

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

Written and edited by GLP ChartAbout this siteContact
Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.